Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
|
US |
|
Nusa Palapa Gemilang Tbk PT
IDX:NPGF
|
ID |
|
Rumble Resources Ltd
ASX:RTR
|
AU |
|
Apex Frozen Foods Ltd
NSE:APEX
|
IN |
|
MiraeAsset Maps REIT 1 Co Ltd
KRX:357250
|
KR |
|
B
|
BIGG Digital Assets Inc
CNSX:BIGG
|
CA |
|
Sunopta Inc
F:ZSK
|
US |
|
LF Corp
KRX:093050
|
KR |
|
BBMG Corp
SSE:601992
|
CN |
|
JCDecaux SA
OTC:JCDXF
|
FR |
Wall Street
Price Targets
MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc
According to Wall Street analysts, the average 1-year price target for
MRVI
is 4.42 USD
with a low forecast of 3.03 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MRVI's stock price target?
Price Target
4.42
USD
According to Wall Street analysts, the average 1-year price target for
MRVI
is 4.42 USD
with a low forecast of 3.03 USD and a high forecast of 5.25 USD.
What is Maravai LifeSciences Holdings Inc's Revenue forecast?
Projected CAGR
9%
For the last 6 years the
compound annual growth rate for
Maravai LifeSciences Holdings Inc's revenue is
4%.
The projected
CAGR
for the next 3 years is
9%.
